FSHD NEWS: How CRISPR could lead to a cure for muscular dystrophy

Your donations have played a part in this important discovery for a potential treatment and cure for FSHD. The Chris Carrino Foundation for FSHD is acknowledged in the official paper for this research. Your continued support is crucial to advance these findings. Thanks to Dr. Jones and his team for their dedication.


 November 19, 2015

A visual representation of how the new CRISPR technology can “turn off” a gene that causes a form of muscular dystrophy. (Peter Jones/University of Massachusetts Medical School)

The promise of new CRISPR gene-editing technology has always been that it might lead to a cure for specific genetic diseases. Recently published findingsfrom a team of researchers at the University of Massachusetts Medical School in Worcester, Mass., suggest that a modified form of this CRISPR gene-editing technology may eventually result in a cure for facioscapulohumeral muscular dystrophy (FSHD), a form of the disease that leads to progressive muscular degeneration in the face, shoulder blades and upper arms.



Join us for The Chris Carrino Foundation Virtual Gala on October 22, 2020!  REGISTER TODAY!